País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Minoxidil
Pfizer Ltd
C02DC01
Minoxidil
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050100; GTIN: 5012882005153
LONITEN ® 5 MG TABLETS LONITEN ® 10 MG TABLETS (minoxidil) PATIENT INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. Your medicine is available using any of the above names but will be referred to as Loniten throughout this leaflet. Also available in 2.5 mg tablets. WHAT IS IN THIS LEAFLET 1. What Loniten is and what it is used for 2. What you need to know before you take Loniten 3. How to take Loniten 4. Possible side effects 5. How to store Loniten 6. Contents of the pack and other information 1. WHAT LONITEN IS AND WHAT IT IS USED FOR This medicine contains minoxidil, which is one of a group of medicines called ‘vasodilators’. It can be used to treat very high blood pressure (hypertension), and works by relaxing blood vessels so that blood passes through them more easily. This helps to lower blood pressure. You must talk to your doctor or pharmacist if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LONITEN DO NOT TAKE LONITEN: - If you are allergic to minoxidil or any of the other ingredients of this medicine (listed in section 6). - If your high blood pressure is caused by hormones from a tumour (phaeochromocytoma), usually near the kidneys. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Loniten: - If you are pregnant or trying to become pregnant. - If you have heart failure (you may feel breathless, wheezy or tired and your ankles may swell up); - If you have ever had a heart attack. Loniten tablets encourage salt and water to remain i Leia o documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Loniten 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Loniten tablet contains 10 mg minoxidil. Excipients with known effect: Each tablet contains 90.3 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Round white to light tan biconvex tablets, with ‘10' imprinted on one side, scored on the reverse with a‘U’ on one side of the score and ‘137’ on the other side. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Minoxidil is indicated for the treatment of severe hypertension. It should not be used as the sole agent to initiate therapy. It is a peripheral vasodilator and should be given in conjunction with a diuretic, to control salt and water retention, and a beta-adrenergic blocking agent, or appropriate substitute, to control reflex tachycardia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Patients over 12 years and adults _ The recommended starting dose is 5 mg per day. If required, this dosage can later be increased up to 20 mg, and then to 40 mg daily (given as a single dose or in two divided doses). Dose increases should be made at increments of 5 mg to 10 mg minoxidil per day at intervals of three or more days. If a dose of 50 mg of minoxidil has been reached, the dose may be increased by 25 mg minoxidil per day to a maximum dose of 100 mg per day. If the desired decrease of diastolic blood pressure exceeds 30 mmHg, dosage should be divided to two daily doses to keep daily blood pressure fluctuations as low as possible. _Patients younger than 12 years of age _ The use of minoxidil in children is restricted to children with severe hypertension associated with target organ damage where other treatment has failed. The data regarding the use of minoxidil in children is very limited, especially in infants. The dosage recommendations can only be considered as a rough guide to treatment at present as this is based on Leia o documento completo